BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32811557)

  • 1. Estimating length of stay and inpatient charges attributable to hospital-acquired bloodstream infections.
    Zhang Y; Du M; Johnston JM; Andres EB; Suo J; Yao H; Huo R; Liu Y; Fu Q
    Antimicrob Resist Infect Control; 2020 Aug; 9(1):137. PubMed ID: 32811557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hospital-acquired, laboratory-confirmed bloodstream infection: increased hospital stay and direct costs.
    Orsi GB; Di Stefano L; Noah N
    Infect Control Hosp Epidemiol; 2002 Apr; 23(4):190-7. PubMed ID: 12002233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nosocomial bloodstream infections on mortality, length of stay, and hospital costs in older adults.
    Kaye KS; Marchaim D; Chen TY; Baures T; Anderson DJ; Choi Y; Sloane R; Schmader KE
    J Am Geriatr Soc; 2014 Feb; 62(2):306-11. PubMed ID: 24438554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health care institutional charges associated with ambulatory bloodstream infections in pediatric oncology and stem cell transplant patients.
    Wong Quiles CI; Gottsch S; Thakrar U; Fraile B; Billett AL
    Pediatr Blood Cancer; 2017 Feb; 64(2):324-329. PubMed ID: 27555523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burden of bloodstream infection caused by extended-spectrum β-lactamase-producing enterobacteriaceae determined using multistate modeling at a Swiss University Hospital and a nationwide predictive model.
    Stewardson A; Fankhauser C; De Angelis G; Rohner P; Safran E; Schrenzel J; Pittet D; Harbarth S
    Infect Control Hosp Epidemiol; 2013 Feb; 34(2):133-43. PubMed ID: 23295559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Impact of extended-spectrum β-lactamase on clinical outcome and medical cost in patients with bloodstream infection due to Klebsiella pneumoniae].
    Li JQ; Tang CQ; Wang H; Ji SZ; Lü KY; Xiao SC; Deng AM; Huang Y; Xia ZF
    Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(24):1903-6. PubMed ID: 27373357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are there differences in hospital cost between patients with nosocomial methicillin-resistant Staphylococcus aureus bloodstream infection and those with methicillin-susceptible S. aureus bloodstream infection?
    Ben-David D; Novikov I; Mermel LA
    Infect Control Hosp Epidemiol; 2009 May; 30(5):453-60. PubMed ID: 19344266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costs and length of stay associated with antimicrobial resistance in acute kidney injury patients with bloodstream infection.
    Vandijck DM; Blot SI; Decruyenaere JM; Vanholder RC; De Waele JJ; Lameire NH; Claus S; De Schuijmer J; Dhondt AW; Verschraegen G; Hoste EA
    Acta Clin Belg; 2008; 63(1):31-8. PubMed ID: 18386763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Costs Associated with Bloodstream Infections Caused by Multidrug-Resistant Gram-Negative Bacteria Are Due Primarily to Patients with Hospital-Acquired Infections.
    Thaden JT; Li Y; Ruffin F; Maskarinec SA; Hill-Rorie JM; Wanda LC; Reed SD; Fowler VG
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27993852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attributable costs of enterococcal bloodstream infections in a nonsurgical hospital cohort.
    Butler AM; Olsen MA; Merz LR; Guth RM; Woeltje KF; Camins BC; Fraser VJ
    Infect Control Hosp Epidemiol; 2010 Jan; 31(1):28-35. PubMed ID: 19951200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attributable cost and length of stay for central line-associated bloodstream infections.
    Goudie A; Dynan L; Brady PW; Rettiganti M
    Pediatrics; 2014 Jun; 133(6):e1525-32. PubMed ID: 24799537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospital-acquired, laboratory-confirmed bloodstream infections: linking national surveillance data to clinical and financial hospital data to estimate increased length of stay and healthcare costs.
    Vrijens F; Hulstaert F; Van de Sande S; Devriese S; Morales I; Parmentier Y
    J Hosp Infect; 2010 Jul; 75(3):158-62. PubMed ID: 20381900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costs of healthcare- and community-associated infections with antimicrobial-resistant versus antimicrobial-susceptible organisms.
    Neidell MJ; Cohen B; Furuya Y; Hill J; Jeon CY; Glied S; Larson EL
    Clin Infect Dis; 2012 Sep; 55(6):807-15. PubMed ID: 22700828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The healthcare costs of antimicrobial resistance in Lebanon: a multi-centre prospective cohort study from the payer perspective.
    Iskandar K; Roques C; Hallit S; Husni-Samaha R; Dirani N; Rizk R; Abdo R; Yared Y; Matta M; Mostafa I; Matta R; Salameh P; Molinier L
    BMC Infect Dis; 2021 May; 21(1):404. PubMed ID: 33933013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality.
    Pittet D; Tarara D; Wenzel RP
    JAMA; 1994 May; 271(20):1598-601. PubMed ID: 8182812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Length of stay, cost, and mortality of healthcare-acquired bloodstream infections in children and neonates: A systematic review and meta-analysis.
    Karagiannidou S; Triantafyllou C; Zaoutis TE; Papaevangelou V; Maniadakis N; Kourlaba G
    Infect Control Hosp Epidemiol; 2020 Mar; 41(3):342-354. PubMed ID: 31898557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costs and savings associated with infection control measures that reduced transmission of vancomycin-resistant enterococci in an endemic setting.
    Montecalvo MA; Jarvis WR; Uman J; Shay DK; Petrullo C; Horowitz HW; Wormser GP
    Infect Control Hosp Epidemiol; 2001 Jul; 22(7):437-42. PubMed ID: 11583213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healthcare-associated Staphylococcus aureus bloodstream infection: length of stay, attributable mortality, and additional direct costs.
    Primo MG; Guilarde AO; Martelli CM; Batista LJ; Turchi MD
    Braz J Infect Dis; 2012; 16(6):503-9. PubMed ID: 23158266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital.
    Warren DK; Quadir WW; Hollenbeak CS; Elward AM; Cox MJ; Fraser VJ
    Crit Care Med; 2006 Aug; 34(8):2084-9. PubMed ID: 16763511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost of intensive care unit-acquired bloodstream infections.
    Laupland KB; Lee H; Gregson DB; Manns BJ
    J Hosp Infect; 2006 Jun; 63(2):124-32. PubMed ID: 16621137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.